iTonic Holdings Ltd Class A (ITOC)
NASDAQ: ITOCHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ITOC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $11.63M
- EPS (TTM)
- -$4.22
- Dividend yield
- None
- 52-week range
- 1.40 – 18.40
- Day range
- 1.45 – 1.81
- Volume / Avg
- 160.43K / 42.84K
- Beta
- —
- Shares outstanding
- 6.84M
52-week range
ITOC stock today
Shares of iTonic (ITOC) finished higher on Nov 20 at $1.59, a gain of 6.00% or $0.09 per share, versus the S&P 500's 3.70% decline. Volume was 3.7x the average at 160.43K shares, a sign of unusually heavy trading. Shares are 91.4% below their 52-week high of $18.40, set on Jun 8, 2026 and 13.6% above the 52-week low of $1.40, near the bottom of the past year's range.
ITOC is down 76.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 82.0%. iTonic has posted a net loss over the last twelve months (EPS of -$4.22), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About iTonic
Company profileiTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Jianfei Zhang
- Headquarters
- Beijing
- Employees
- 7
- IPO year
- 2024
- Website
- ftzy.com.cn
Financial highlights
Full financialsIn fiscal 2025, iTonic generated $523,031 in revenue, up 16.7% from fiscal 2024. iTonic reported a net loss of $5.1 million, compared with a loss of $660,588 a year earlier. Gross margin was 62.6% (down from 85.0%) and operating margin -991.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $523.03K | $448.20K | $628.59K | $679.78K |
| Growth | +16.70% | -28.70% | -7.53% | — |
| Net income | $-5.10M | $-660.59K | $-241.22K | $83.98K |
| EPS (diluted) | $-0.318 | $-0.052 | $-0.02 | $0.007 |
ITOC news
All ITOC newsiTonic peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IRIXIRIDEX Corporation | 0.4449 | -4.59% | $7.92M | vs ITOC |
| NDRAENDRA Life Sciences Inc. | 3.58 | -3.38% | $5.36M | vs ITOC |
| NUWENuwellis Inc. | 3.41 | -10.50% | $1.84M | vs ITOC |
| NXLNexalin Technology Inc. | 1.38 | -2.13% | $1.71M | vs ITOC |
| VBIOValion Bio Inc. | 0.4806 | -10.98% | $1.04M | vs ITOC |
| QTIQT Imaging Holdings Inc. | 1.92 | +2.67% | $28.21M | vs ITOC |
| ECORelectroCore Inc. | 4.42 | -8.87% | $40.78M | vs ITOC |
| POCIPrecision Optics Corporation Inc. | 4.12 | +1.41% | $45.30M | vs ITOC |
Indexes, lists and sector
iTonic stock FAQ
What is iTonic's stock price today?
ITOC last traded at $1.59 as of Nov 20, 4:00 PM EST, up 6.00% on the day. Prices are delayed at least 15 minutes.
Does iTonic pay a dividend?
No. iTonic does not currently pay a regular cash dividend.
Who is iTonic's CEO?
Mr. Jianfei Zhang is the chief executive officer of iTonic Holdings Ltd Class A, which has about 7 employees.
Has ITOC ever split its stock?
Yes. The most recent ITOC stock split was a 1-for-16 split on Oct 6, 2026.
What is the ITOC 52-week high?
The 52-week high for ITOC is $18.40 and the 52-week low is $1.40. The stock is currently 91.4% below its high.